Logistic regression for the outcome of AF recurrence after two PVIs
| Univariate B (95% CI), p value | Multivariate* B (95% CI), p value | |
| Age (years) | 1.01 (0.98 to 1.04), p=0.683 | |
| Female sex | 1.24 (0.65 to 2.34), p=0.515 | |
| Duration of AF | 1.00 (1.00 to 1.00), p=0.533 | |
| Non-paroxysmal AF | 1.07 (1.00 to 1.13), p=0.038 | 1.08 (1.01 to 1.15), p=0.033 |
| eGFR | 0.97 (0.95 to 0.99), p=0.011 | 0.96 (0.94 to 0.99), p=0.009 |
| Body mass index | 1.04 (0.97 to 1.11), p=0.259 | |
| Bundle branch block | 2.88 (1.12 to 7.40), p=0.029 | 4.17 (1.38 to 12.58), p=0.011 |
| Diabetes mellitus | 0.24 (0.33 to 1.84), p=0.173 | |
| Hypertension | 0.95 (0.50 to 1.80), p=0.877 | |
| Heart failure | 3.92 (1.58 to 9.71), p=0.003 | 4.70 (1.49 to 14.86), p=0.008 |
| Coronary artery disease | 0.85 (0.29 to 2.45), p=0.757 | |
| Vascular disease | 1.35 (0.30 to 6.06), p=0.691 | |
| CVA | 1.33 (0.45 to 3.93), p=0.606 | |
| Prior AAD use | 1.15 (0.59 to 2.25), p=0.684 | |
| Amiodarone use | 1.47 (0.63 to 3.45), p=0.375 | |
| LAVI | 1.04 (1.01 to 1.08), p=0.015 | 1.04 (1.01 to 1.08), p=0.046 |
| LVEF | 0.97 (0.92 to 1.03), p=0.355 |
*Adjusting for other baseline variables.
AAD, antiarrhythmic drug; AF, atrial fibrillation; CVA, cerebrovascular accident; eGFR, estimated glomerular filtration rate; LAVI, Left Atrium Volume Index; LVEF, left ventricular ejection fraction; PVI, pulmonary vein isolation.